DOI: https://dx.doi.org/10.18203/2320-1770.ijrcog20220192
Published: 2022-01-28

The impact of Hashimoto’s disease on female fertility: a systematic review

Antigoni Sarantaki, Kyriaki Tsiorou, Kleanthi Gourounti

Abstract


Hashimoto’s disease (HT) is the most common autoimmune disease, affecting 5–15% of women of reproductive age. Recent studies have shown that Hashimoto’s thyroiditis can be a risk factor for infertility in women. The aim of the present study is to explore the impact of Hashimoto’s disease on female fertility. This systematic review followed the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Databases searched included Medline, PubMed, EMBASE and Google Scholar. Search terms included Hashimoto’s disease, Hashimoto’s thyroiditis, thyroid autoimmunity, autoimmune thyroiditis, women, females, infertility and every possible combination of them. The exclusion criteria of this systematic review involved articles written in a language other than English, other disorders that also affect the female fertility, women with infertile partners, with abnormal karyotype or/and with abnormal body mass index (BMI). The search strategy identified 150 unique items. After the initial screening process, 50 studies underwent full text review and 5 studies were finally included in the systematic review, since they met all the inclusion criteria. Four of the included studies found that Hashimoto’s thyroiditis can have a negative effect on female fertility and especially in patients of advanced age. Women with autoimmune thyroiditis might be at risk of ovarian insufficiency because of the decline in ovarian reserve. Consequently, patients with positive anti-thyroid peroxidase (TPO) antibody findings, who wish to start a family, should be aware of their lower reproductive life span. Further randomized controlled trials can clarify the impact of Hashimoto’s disease on female fertility.


Keywords


Autoimmune thyroiditis, Hashimoto’s disease, Hashimoto’s thyroiditis, Thyroid autoimmunity, Women, Females, Infertility

Full Text:

PDF

References


Verma I, Sood R, Juneja S, Kaur S. Prevalence of hypothyroidism in infertile women and evaluation of response of treatment for hypothyroidism on infertility. Int J Appl Basic Med Res. 2012;2(1):17-9

Ihnatowicz P, Drywień M, Wątor P, Wojsiat J. The importance of nutritional factors and dietary management of Hashimoto's thyroiditis. Ann Agric Environ Med. 2020;27(2):184-93.

Rouland A, Buffier P, Petit JM, Vergès B, Bouillet B. Thyroiditis: What's new in 2019. La Revue de medicine interne. 2020;41(6):390-5.

Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018;62:2-10.

McDermott MT. Thyroid disease and reproductive health. Thyroid. 2004;14(1).

De Vivo A, Mancuso A, Giacobbe A, Moleti M, Maggio Savasta L, De Dominici R, Priolo AM, Vermiglio F. Thyroid function in women found to have early pregnancy loss. Thyroid. 2010;20(6):633-7.

Seungdamrong A, Steiner AZ, Gracia CR, Legro RS, Diamond MP, Coutifaris C, et al. Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women. Fertility and Sterility 2017;108(5):843-50.

ACOG Practice Bulletin, Number 223. Thyroid Disease in Pregnancy. Obstetrics & Gynecology. 2020;135(6):261-74.

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. BMJ. 2009;339:b2535.

Modesti PA, Reboldi G, Cappuccio FP. Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS One. 2016;11(1): e0147601.

Herzog R, Álvarez-Pasquin MJ, Díaz C, Del Barrio JL, Estrada JM, Gil Á. Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review. BMC Public Health. 2013;13(1).

Grossmann B, Saur S, Rall K, Recher AC, Hubner S, Henes J, et al. Prevalence of autoimmune disease in women with premature ovarian failure. Eur J Contracept Reprod Health Care. 2019;25(1):72-5.

Saglam F, Onal ED, Ersoy R, Koca C, Ergin M, Erel O, Cakir B. Anti-Müllerian hormone as a marker of premature ovarian aging in autoimmune thyroid disease. Gynecological Endocrinology. 2014;31(2):165-8.

Samsami A, Ghasmpour L, Moradi Alamdarloo S, Davoodi S, Rahmati J, Karimian A, Tavasoli M. Women with Autoimmune Thyroiditis have Lower Reproductive Life Span or Not? A Cross- Sectional Study. Int J Comm Based Nurs Midwifery. 2020;8(4):305-10.

Pirgon O, Sivrice C, Demirtas H, Dundar B. Assessment of ovarian reserve in euthyroid adolescents with Hashimoto thyroiditis. Gynecological Endocrinology. 2016;32(4):306-10.

Quintino-Moro A, Zantut-Wittmann DE, Tambascia M, Machado Hda C, Fernandes A. High Prevalence of Infertility among Women with Graves' Disease and Hashimoto's Thyroiditis. Int J Endocrinol. 2014:982705.

Muttukrishna S, McGarrigle H, Wakim R. Antral follicle count, anti-Mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG. 2005;112:1384-90.

Unuane D, Velkeniers B. Impact of thyroid disease on fertility and assisted conception. Best Pract Res Clin Endocrinol Metabol. 2020;34(4):101378.